Yoosakul, E., C. Seeduang, B. Chuasuwan, C. Manamuti, P. Pitisuttithum, B. Karachot, and I. Techatanawat. “Comparative Randomized, Single Dose, Two-Way Crossover, Open-Label Study to Determine the Bioequivalence of Irbesartan Formulation, Irbesartan GPO 150 Mg Tablets and Aprovel® 150 Mg Tablets, After Oral Administration to Healthy Thai Volunteers under Fasti”. Journal of Health Research, vol. 30, no. 3, Feb. 2017, pp. 199-05, https://he01.tci-thaijo.org/index.php/jhealthres/article/view/77939.